Top compounds associated with response to SLC22A13


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.064 0.07
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.07
mRNA tivozanib GDSC1000 pan-cancer AAC 0.059 0.07
mRNA alisertib CTRPv2 pan-cancer AAC -0.057 0.07
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.061 0.08
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.066 0.08
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.084 0.08
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.064 0.08
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.058 0.08
Download CSV